Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial

Javier Arpa, Irene Sanz‐Gallego, Francisco Javier Rodríguez de Rivera Garrido, Francisco J. Domínguez-Melcón, Daniel Prefasi, Javier Oliva-Navarro, Mar Moreno-Yangüela

Acta Neurologica Scandinavica · 2013 · 47 citations · 28 references

Abstract

Our results seem to indicate some uncertain benefit on the neurological and heart functions of this triple therapy in FRDA.

References

28